Sora focuses her practice on a variety of life sciences and technology transactions. Her experience includes assisting clients in drafting and negotiating agreements involving the research, development and commercialization of new technologies and products, software licensing, and manufacturing and supply relationships. Sora also provides support on the intellectual property aspects of mergers and acquisitions.
A patient access and experience-focused mental health company on the development of a digital ecosystem to facilitate patient access to mental healthcare.
Multiple biopharmaceutical companies on their license, option and collaborations agreements to develop and commercialize drug products and biologics.
Emerging California-based gene therapy platform on a research collaboration and licensing agreement with a leading biopharmaceutical company to create tissue-targeted gene therapies for three CNS disease targets, including ~$100m upfront cash and equity payment, $500m+ in option and development milestone payments, and high single-digit royalty payments on future product sales.
A leading provider of antimicrobial technology on its collaboration for the development and commercialization of antimicrobial products.
Multiple digital health, medical device, bioengineering, medical technology, and biotechnology companies on their strategic technology and services contracts.
Walker & Dunlop on the IP aspects of its $744m acquisition of Alliant Capital, Ltd. and its affiliates, Alliant Strategic Investments and ADC Communities.
Walker & Dunlop on advice regarding the IP aspects of its investments in technology companies.